Investment Companies Roundup Kindly sponsored by Baillie Gifford and Aberdeen Standard Investments Table of contents New research In this issue Performance data Discounts and premiums Money in and out Major news stories Income Events Guide Appendix – Performance by sector full list New research Here is a list of research we published over March: An update note […]
In QuotedData’s other news 10 February 2020 – Intu Properties (INTU) confirmed that further to press speculation, it is engaged in discussions with shareholders and new investors, in relation to a proposed equity raise alongside the company’s full year results at the end of February. INTU says it will make further announcements in due course, […]
In this issue The sector at the end of 2019 Performance data Performance by sector and fund Money in and out of the sector Money in and out of existing funds Money coming into existing funds Money going out of existing funds Liquidations, de-listings and trading cancellations Significant rating changes Major news stories Outlook for […]
Biotech Growth tops bio-trust league with 47% NAV rise – Orbimed-managed Biotech Growth Trust (BIOG) recorded the rise 47% rise in NAV in 2019, representing the best performance of the 14 specialist biotech/pharma closed end investment vehicles monitored by Marten & Co. Biotech Growth’s rise in NAV was more than double that of the benchmark […]
Investment Companies Roundup Kindly sponsored by Baillie Gifford Table of contents New research In this issue Performance data Discounts and premiums Money in and out Income Events New research Here is a list of research we published over November: An initiation note on Henderson High Income “We have initiated coverage on Henderson High Income (HHI). Since […]
Investment Companies Roundup Kindly sponsored by Baillie Gifford New research Over October, we published notes on Pacific Horizon, Seneca Global Income & Growth, Premier Global Infrastructure, Polar Capital Global Financials, Ecofin Global Utilities and Infrastructure, Aberdeen Standard European Logistics Income and Herald. Additionally, as part of our enhanced coverage of the property sector, we launched […]
In QuotedData’s other news 29 October – Bill Ackman-managed Pershing Square Holdings (PSH) has announced an additional share buyback program worth $100m of PSH’s outstanding shares on the London Stock Exchange and Euronext Amsterdam. PSH says the program will begin following the completion of the previously announced $100m buyback program. They add that the program […]
Trust favourite Alexion acquires complentary player Achillion Rare disease specialist and investment trust favourite Alexion Pharmaceuticals (NASDAQ:ALXN) has notched up its second business development transaction in a just over a week, with a $1bn deal to acquire the smaller US competitor Achillion Pharmaceuticals (NASDAQ:ACHN). The acquisition follows the option deal covering StealthBioTherapeutics’ Phase II stage drug […]
Investment Companies Quarterly Roundup Kindly sponsored by Baillie Gifford New research Over the third quarter, we published notes on India Capital Growth, Jupiter Emerging & Frontier Income, Montanaro European Smaller Companies, JLEN Environmental Assets, Civitas Social Housing, JPMorgan Russian Securities, International Biotechnology Trust, Aberdeen Emerging Markets, Seneca Global Income & Growth, Standard Life Investments Property Income […]
Trust favourite Alexion options Stealth Bio’s mitochrondrial disease drug US rare disease biotech and investment trust favourite Alexion Pharmaceuticals (NASDAQ:ALXN) has effectively added a new Phase III-stage programme to its R&D pipeline, by virture of an option deal covering Stealth BioTherapeutics’ lead product elamipretide for mitochondrial diseases. Stealth (NASDAQ:MITO), a $270m market cap US biotech […]
